| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.091 | 0.007 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.09 | 0.007 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.084 | 0.007 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.088 | 0.009 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.073 | 0.01 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.01 |